Trial NCT02709889

View at ClinicalTrials.gov 
Org. Study IDs: SCRX001-006

Last trial update was posted on 2020-10-19

MeSH Interventions

Dexamethasone Rovalpituzumab tesirine

MeSH Conditions

Carcinoma Carcinoma, Neuroendocrine Glioblastoma Melanoma

Other Conditions

High Grade Gastroenteropancreatic Neuroendocrine Carcinoma Large-Cell Neuroendocrine Carcinoma Malignant Melanoma Medullary Thyroid Cancer Neuroendocrine Prostate Cancer Other Neuroendocrine Carcinoma Other Solid Tumors

Stopping Reasons

Strategic considerations

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID